SE7608909L - Sett att framstella en vattenhaltig, injicerbar acetylsalicylsyralosning - Google Patents

Sett att framstella en vattenhaltig, injicerbar acetylsalicylsyralosning

Info

Publication number
SE7608909L
SE7608909L SE7608909A SE7608909A SE7608909L SE 7608909 L SE7608909 L SE 7608909L SE 7608909 A SE7608909 A SE 7608909A SE 7608909 A SE7608909 A SE 7608909A SE 7608909 L SE7608909 L SE 7608909L
Authority
SE
Sweden
Prior art keywords
injectible
aquatic
prepare
way
acid solution
Prior art date
Application number
SE7608909A
Other languages
English (en)
Inventor
J Bru
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Publication of SE7608909L publication Critical patent/SE7608909L/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE7608909A 1975-08-11 1976-08-10 Sett att framstella en vattenhaltig, injicerbar acetylsalicylsyralosning SE7608909L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7524981A FR2320759A1 (fr) 1975-08-11 1975-08-11 Solution d'acide acetylsalicylique extemporanee injectable

Publications (1)

Publication Number Publication Date
SE7608909L true SE7608909L (sv) 1977-02-12

Family

ID=9158984

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608909A SE7608909L (sv) 1975-08-11 1976-08-10 Sett att framstella en vattenhaltig, injicerbar acetylsalicylsyralosning

Country Status (10)

Country Link
JP (1) JPS5241212A (sv)
AU (1) AU1673776A (sv)
BE (1) BE845038A (sv)
DE (1) DE2635843A1 (sv)
ES (1) ES450583A1 (sv)
FR (1) FR2320759A1 (sv)
GB (1) GB1525765A (sv)
NL (1) NL7608951A (sv)
SE (1) SE7608909L (sv)
ZA (1) ZA764781B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6021570B2 (ja) * 1978-07-04 1985-05-28 三共株式会社 ド−パ類の高濃度製剤の製法
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
DE602006005423D1 (de) * 2005-06-29 2009-04-16 Verisfield Uk Ltd Pharmazeutische Zusammensetzungen von Risperidon in wässriger Lösung
CN101380329B (zh) * 2008-10-29 2010-11-17 海南本创医药科技有限公司 一种精氨酸阿司匹林及其粉针剂的制备方法
US20120270846A2 (en) * 2009-05-11 2012-10-25 King Saud University Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration
CN102531969A (zh) * 2011-12-28 2012-07-04 蚌埠丰原医药科技发展有限公司 一种无菌l-精氨酸的制备方法
US11918554B2 (en) 2016-06-28 2024-03-05 Asamedic As Two-component composition
EP3501522A1 (en) 2017-12-22 2019-06-26 Asamedic AS Compositions comprising acetylsalicylic acid and a phosphate salt
EP3501523A1 (en) 2017-12-22 2019-06-26 Asamedic AS Two-component compositions comprising acetyl salicylic acid and a carbonate salt
WO2023198294A1 (en) * 2022-04-14 2023-10-19 Hyloris Developments Sa Acetyl salicylic acid composition for intravenous administration, its storage, production and use

Also Published As

Publication number Publication date
FR2320759B1 (sv) 1979-09-14
NL7608951A (nl) 1977-02-15
GB1525765A (en) 1978-09-20
ES450583A1 (es) 1978-02-01
DE2635843A1 (de) 1977-02-24
JPS5241212A (en) 1977-03-30
AU1673776A (en) 1978-02-16
FR2320759A1 (fr) 1977-03-11
ZA764781B (en) 1977-07-27
BE845038A (fr) 1976-12-01

Similar Documents

Publication Publication Date Title
SE441528B (sv) Sett att framstella nya 3-kinolin-karboxylsyraderivat
SE426583B (sv) Sett att framstella etylidenacetat
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE7611761L (sv) Sett att framstella modifierad polysackarid
NL7503553A (nl) 16-geoxygeneerde prostaanzuurderivaten.
SE433492B (sv) Sett att framstella fenylettiksyraderivat
SE7606280L (sv) Sett att framstella etrar
SE7607240L (sv) Sett att framstella pyrrolettiksyraforeningar
SE7607152L (sv) Sett att framstella nya 2-piperidinoalkyl-1,4-bensdioxaner
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE393191B (sv) Vattenhaltig kolesterol-standardlosning
SE7608909L (sv) Sett att framstella en vattenhaltig, injicerbar acetylsalicylsyralosning
SE7602729L (sv) Sett att framstella nya indolylalkylpiperidiner
SE435280B (sv) Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat
SE7604890L (sv) Sett att framstella perkarbonsyralosningar
SE434842B (sv) Sett att framstella nya 7-amino-tiazolyl-acetamido-cefalosporansyraderivat
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
NL7505481A (nl) 13-thiaprostaanzuurderivaten.
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE7505595L (sv) Sett att framstella abietamidderivat.
SE415653B (sv) Sett att framstella cykloalkylfenoxikarboxylsyraderivat
SE7607171L (sv) Sett att framstella indolokinoliziner
SE7508779L (sv) Sett att framstella prostaninsyraderivat